Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive...
Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 3 3244 3000
Address:
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Japan
